ACTL6A通过调控GPX4介导的铁死亡促进弥漫大B细胞淋巴瘤细胞多柔比星耐药OA
Study on the role of ACTL6A in promoting doxorubicin resistance in diffuse large B cell lymphoma cells by regulating GPX4-mediated ferroptosis
目的:探究肌动蛋白样蛋白6A(ACTL6A)通过调控铁死亡参与弥漫大B细胞淋巴瘤(DLBCL)细胞多柔比星(DOX)耐药的机制.方法:培养亲本DLBCL细胞SU-DHL-4与耐药细胞SU-DHL-4/DOX,qPCR和WB法检测ACTL6A表达变化;通过转染携带靶向ACTL6A干扰序列(sh-ACTL6A)及其阴性对照(sh-NC)的质粒,构建敲减ACTL6A的SU-DHL-4/DOX,qPCR和WB法检测转染后细胞中ACTL6A、铁死亡相关蛋白谷胱甘肽过氧化酶4(GPX4)、溶质载体家族7成员11(SLC7A11)、长链酰基辅酶A合成酶4(ACSL4)的表达水平,染色质免疫沉淀(ChIP)、双萤光素酶报告基因实验验证ACTL6A与GPX4间的靶向结合与调控作用.将SU-DHL-4/DOX细胞分为对照组、sh-NC组、sh-ACTL6A组、sh-NC+oe-GPX4组和sh-ACTL6A+oe-GPX4组,用转染试剂将相应质粒转染至细胞中,qPCR和WB法检测各组细胞中ACTL6A和GPX4表达水平,CCK-8法检测不同浓度DOX处理后各组细胞存活率,FerroOrange探针检测各组细胞中亚铁离子(Fe2+)水平,Liperfluo探针检测各组细胞中脂质过氧化物水平,DCFH-DA探针检测各组细胞中活性氧(ROS)水平,比色法检测各组细胞中谷胱甘肽(GSH)和丙二醛(MDA)含量.结果:与SU-DHL-4细胞相比,SU-DHL-4/DOX细胞中ACTL6A mRNA和蛋白均呈高表达(均P<0.05);ACTL6A与GPX4间存在靶向结合关系;敲减ACTL6A后SU-DHL-4/DOX细胞中ACTL6A和GPX4 mRNA及其蛋白表达水平均明显下降(均P<0.05),表明ACTL6A可调控GPX4的表达;敲减ACTL6A可抑制SU-DHL-4/DOX细胞的存活率,促进细胞内Fe2+、脂质过氧化物、ROS、MDA的生成,抑制GSH生成(均P<0.05);而在敲减ACTL6A的同时过表达GPX4可上调SU-DHL-4/DOX细胞中GPX4的mRNA及其蛋白表达水平(均P<0.05),并提高细胞存活率,抑制细胞内Fe2+、脂质过氧化物、ROS、MDA 的生成,并增加 GSH 生成(均P<0.05).结论:ACTL6A在DOX耐药DLBCL细胞中高表达,通过调控GPX4表达抑制铁死亡,促进DLBCL细胞耐药.
Objective:To investigate the mechanism by which actin-like protein 6A(ACTL6A)regulates ferroptosis and contributes to doxorubicin(DOX)resistance in diffuse large B cell lymphoma(DLBCL)cells.Methods:The parental DLBCL cell line SU-DHL-4 cells and its DOX-resistant variant SU-DHL-4/DOX cells were cultured.Changes in the expression of ACTL6A were detected by qPCR and WB assay.SU-DHL-4/DOX cells with ACTL6A knockdown were constructed by transfecting plasmids carrying a short hairpin RNA targeting ACTL6A(sh-ACTL6A)or its negative control(sh-NC).The expression levels of ACTL6A and ferroptosis-related proteins,including glutathione peroxidase 4(GPX4),solute carrier family 7 member 11(SLC7A11),and acyl-CoA synthetase long-chain family member 4(ACSL4),were measured using qPCR and WB.Chromatin immunoprecipitation(ChIP)and dual-luciferase reporter assays were performed to verify the targeting and regulatory relationship between ACTL6A and GPX4.SU-DHL-4/DOX cells were divided into Control,sh-NC,sh-ACTL6A,sh-NC+oe-GPX4,and sh-ACTL6A+oe-GPX4 groups.Corresponding plasmids were transfected into the cells.CCK-8 assay was used to detect cell survival rates of each group under different concentrations of DOX treatment.FerroOrange,Liperfluo,and DCFH-DA probes were used to detect ferrous ion(Fe2+)levels,lipid peroxidation,and reactive oxygen species(ROS)in each group of cells,respectively.A colorimetric method was used to measure the contents of glutathione(GSH)and malondialdehyde(MDA)in each group of cells.Results:Both ACTL6A mRNA and protein were highly expressed in SU-DHL-4/DOX cells(both P<0.05),compared to SU-DHL-4 cells.ACTL6A and GPX4 have a targeting binding relationship.Knockdown of ACTL6A significantly decreased the mRNA and protein expression of ACTL6A and GPX4 in SU-DHL-4/DOX cells(both P<0.05),indicating that ACTL6A regulates GPX4 expression.Knockdown of ACTL6A significantly inhibited the survival of SU-DHL-4/DOX cells,increased intracellular Fe2+,lipid peroxides,ROS,and MDA levels,and inhibited GSH production(all P<0.05).However,overexpression of GPX4 in ACTL6A-knockdown cells upregulated the mRNA and protein expression levels of GPX4 in SU-DHL-4/DOX cells(both P<0.05),increased cell survival rate,inhibited the production of intracellular Fe2+,lipid peroxides,ROS,and MDA,and increased GSH production(all P<0.05).Conclusion:ACTL6A is highly expressed in DOX-resistant DLBCL cells.By regulating GPX4 expression,ACTL6A inhibits ferroptosis and promotes drug resistance in DLBCL cells.
王铃;任昳敏;胡彩华;缪宗
东南大学附属南通市第一人民医院 血液内科,江苏 南通 226000复旦大学附属华山医院 血液内科,上海 200040东南大学附属南通市第一人民医院 血液内科,江苏 南通 226000海军军医大学第一附属医院 脑外科,上海 200433
医药卫生
肌动蛋白样6A弥漫大B细胞淋巴瘤多柔比星铁死亡谷胱甘肽过氧化酶4
actin-like protein 6A(ACTL6A)diffuse large B cell lymphoma(DLBCL)doxorubicin(DOX)ferroptosisglutathione peroxidase 4(GPX4)
《中国肿瘤生物治疗杂志》 2026 (3)
243-251,9
国家自然科学青年基金(82303915)中国青年创业就业基金南通大学临床医学专项科研基金(2023JY001)
评论